EVONETIX LTD (‘Evonetix’), the synthetic biology company bringing semiconductor technology to DNA synthesis, has...

Be first to hear about developments in our technology platform and get access to early release and evaluation opportunities.
EVONETIX LTD (‘Evonetix’), the synthetic biology company bringing semiconductor technology to DNA synthesis, has...
IP covers novel method for assembly and error removal in DNA synthesis on silicon chips Patented technology will...
IP covers proprietary thermally-controlled synthesis chemistry, as well as design and manufacture of silicon chips...
Proprietary thermally-controlled synthesis chemistry will enable production of high quality DNA at scale Key milestone...
Cambridge, UK 23rd September 2021 – EVONETIX LTD (‘Evonetix’), the synthetic biology company developing a desktop...
Evonetix, the synthetic biology company developing a desktop platform for scalable, high-fidelity and rapid gene...
Evonetix, the synthetic biology company developing a desktop platform for scalable, high-fidelity and rapid gene...
Evonetix, the Cambridge-based company pioneering an innovative approach to scalable and high-fidelity gene synthesis,...
Evonetix, the Cambridge-based company pioneering an innovative approach to scalable and high-fidelity gene synthesis,...
PRESS RELEASE 02 March 2020 Evonetix raises $30 million USD (£23 million GBP) Series B investment led by west-coast...